Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea · Delayed Price · Currency is KRW 8,310.00
-10.00 (-0.12%)
Last updated: Jun 4, 2026, 2:19 PM KST
KRX:007570 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 149,136 | 233,921 | 205,533 | 281,258 | 349,981 | 510,655 | |
Market Cap Growth | -35.42% | 13.81% | -26.92% | -19.64% | -31.46% | -57.37% |
Enterprise Value | 226,806 | 341,842 | 341,070 | 394,941 | 436,337 | 605,360 |
Last Close Price | 8320.00 | 12895.00 | 11274.48 | 15257.93 | 18681.48 | 26877.80 |
PE Ratio | 7.34 | 34.77 | 22.76 | - | 18.49 | 36.39 |
Forward PE | - | 49.90 | 49.90 | 49.90 | 49.90 | 49.90 |
PS Ratio | 0.54 | 0.86 | 0.77 | 1.06 | 1.41 | 2.11 |
PB Ratio | 0.58 | 0.97 | 0.86 | 1.22 | 1.47 | 2.25 |
P/TBV Ratio | 0.59 | 1.00 | 0.88 | 1.26 | 1.51 | 2.32 |
P/FCF Ratio | 3.94 | 36.99 | - | 32.19 | 180.62 | 13.07 |
P/OCF Ratio | 3.43 | 19.43 | 36.60 | 19.24 | 59.49 | 9.93 |
EV/Sales Ratio | 0.82 | 1.25 | 1.27 | 1.48 | 1.76 | 2.50 |
EV/EBITDA Ratio | 180.30 | 25.69 | 17.54 | 13.93 | 16.77 | 22.92 |
EV/EBIT Ratio | - | 68.88 | 35.45 | 24.11 | 30.62 | 39.86 |
EV/FCF Ratio | 6.00 | 54.06 | - | 45.21 | 225.19 | 15.50 |
Debt / Equity Ratio | 0.44 | 0.53 | 0.45 | 0.32 | 0.31 | 0.43 |
Debt / EBITDA Ratio | 44.46 | 9.53 | 5.54 | 2.56 | 2.85 | 3.73 |
Debt / FCF Ratio | 2.98 | 20.05 | - | 8.32 | 38.24 | 2.52 |
Net Debt / Equity Ratio | 0.28 | 0.40 | 0.40 | 0.26 | 0.26 | 0.24 |
Net Debt / EBITDA Ratio | 28.81 | 7.30 | 4.88 | 2.08 | 2.36 | 2.08 |
Net Debt / FCF Ratio | 1.93 | 15.37 | -2.91 | 6.75 | 31.75 | 1.41 |
Asset Turnover | 0.61 | 0.61 | 0.65 | 0.67 | 0.60 | 0.56 |
Inventory Turnover | 2.57 | 2.52 | 2.79 | 2.96 | 3.46 | 3.40 |
Quick Ratio | 0.52 | 0.46 | 0.39 | 0.47 | 0.46 | 0.59 |
Current Ratio | 0.93 | 0.86 | 0.80 | 0.89 | 0.82 | 0.81 |
Return on Equity (ROE) | 8.13% | 2.97% | 3.95% | -0.87% | 8.53% | 6.25% |
Return on Assets (ROA) | -0.80% | 0.70% | 1.46% | 2.57% | 2.17% | 2.21% |
Return on Invested Capital (ROIC) | -1.26% | 0.79% | 2.63% | 5.56% | 4.07% | 3.45% |
Return on Capital Employed (ROCE) | -1.90% | 1.70% | 3.50% | 6.50% | 5.50% | 6.00% |
Earnings Yield | 13.40% | 2.95% | 4.39% | -0.86% | 5.54% | 2.75% |
FCF Yield | 25.36% | 2.70% | -15.85% | 3.11% | 0.55% | 7.65% |
Dividend Yield | 1.86% | - | - | 0.98% | - | - |
Payout Ratio | 15.79% | 41.72% | 32.93% | - | 20.34% | 16.74% |
Buyback Yield / Dilution | 6.44% | 2.63% | -2.29% | 0.59% | 0.44% | - |
Total Shareholder Return | 8.30% | 2.63% | -2.29% | 1.57% | 0.44% | - |